BACKGROUND: Venous leg ulcers account for 85% of all lower-extremity ulcers, with treatment costs of 3 billion dollars and loss of 2 million workdays per year. The purpose of this study was to validate the clinical efficacy and cost effectiveness of multidisciplinary guidelines for the diagnosis and treatment of venous leg ulcers. METHODS: Eighty (40 retrospective, 40 prospective) patients from the United States and United Kingdom were enrolled. RESULTS: United States patients were 6.5 times and United Kingdom 2 times more likely to heal if a guideline was followed (P <0.001). A significant decrease was noted in healing time for both the United States and United Kingdom (P <0.01), and the median cost decreased significantly when the guideline was followed (P <0.01). CONCLUSIONS: Implementation of a guideline for diagnosis and treatment of venous leg ulcers resulted in improvement in diagnosis, decrease in healing time, and an increase in healing rates resulting in lower costs.
BACKGROUND:Venous leg ulcers account for 85% of all lower-extremity ulcers, with treatment costs of 3 billion dollars and loss of 2 million workdays per year. The purpose of this study was to validate the clinical efficacy and cost effectiveness of multidisciplinary guidelines for the diagnosis and treatment of venous leg ulcers. METHODS: Eighty (40 retrospective, 40 prospective) patients from the United States and United Kingdom were enrolled. RESULTS: United States patients were 6.5 times and United Kingdom 2 times more likely to heal if a guideline was followed (P <0.001). A significant decrease was noted in healing time for both the United States and United Kingdom (P <0.01), and the median cost decreased significantly when the guideline was followed (P <0.01). CONCLUSIONS: Implementation of a guideline for diagnosis and treatment of venous leg ulcers resulted in improvement in diagnosis, decrease in healing time, and an increase in healing rates resulting in lower costs.
Authors: Rosana E Norman; Michelle Gibb; Anthony Dyer; Jennifer Prentice; Stephen Yelland; Qinglu Cheng; Peter A Lazzarini; Keryln Carville; Karen Innes-Walker; Kathleen Finlayson; Helen Edwards; Edward Burn; Nicholas Graves Journal: Int Wound J Date: 2015-12-03 Impact factor: 3.315
Authors: S Reich-Schupke; J Alm; P Altmeyer; D Bachter; C Bayerl; S Beissert; T Bieber; J Böhmer; D Dill; E Dippel; P Dücker; I Effendy; S El Gammal; P Elsner; A Enk; I Feldmann-Böddeker; H Frank; W Gehring; U Gieler; M Goebeler; T Görge; H Gollnick; S Grabbe; G Gross; W Gudat; A Happ; R Herbst; B Hermes; N-P Hoff; S M John; M Jungelhülsing; M Jünger; M Kaatz; A Kapp; R Kaufmann; J Klode; K Knaber; A König; T Krieg; P Kohl; L Kowalzick; P Lehmann; H Löffler; J Maschke; W Marsch; D Mechtel; P Mohr; I Moll; M Müller; D Nashan; H M Ockenfels; R U Peter; H Pillekamp; R Rompel; T Ruzicka; K Salfeld; C Sander; J Schaller; K Scharffetter-Kochanek; G Schuler; H-J Schulze; T Schwarz; B Splieth; H Stege; W Stolz; A Strölin; H Tran; M Tronnier; J Ulrich; T Vogt; G Wagner; J Welzel; T Willgeroth; U Wollina; D Zillikens; C C Zouboulis; T Zuberbier; M Zutt; M Stücker Journal: Hautarzt Date: 2013-09 Impact factor: 0.751
Authors: Brian T Patt; David Jarjoura; Lynn Lambert; Sashwati Roy; Gayle Gordillo; Richard Schlanger; Chandan K Sen; Rami N Khayat Journal: J Clin Sleep Med Date: 2010-12-15 Impact factor: 4.062
Authors: Rajiv Mallick; Aditya Raju; Chelsey Campbell; Rashad Carlton; David Wright; Kimberly Boswell; Michael Eaddy Journal: Am Health Drug Benefits Date: 2016-11
Authors: Stephanie K Beidler; Christelle D Douillet; Daniel F Berndt; Blair A Keagy; Preston B Rich; William A Marston Journal: J Vasc Surg Date: 2009-04 Impact factor: 4.268